Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (381-390 of 561) with videos related to

Pageof 57
Sort By:
BJU International|October 17, 2022
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicatorsFrancesco Del Giudice, David D'Andrea, Benjamin Pradere, et al.
Urologic Oncology|October 18, 2024
Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinomaMario de Angelis, Letizia Maria Ippolita Jannello, Carolin Siech, et al.
Journal of Racial and Ethnic Health Disparities|August 19, 2024
Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma PatientsMario de Angelis, Letizia Maria Ippolita Jannello, Carolin Siech, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
Prostate Cancer and Prostatic Diseases|June 21, 2022
Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United StatesFrancesco Del Giudice, Jianlin Huang, Shufeng Li, et al.
BJU International|March 18, 2024
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancerMario de Angelis, Andrea Baudo, Carolin Siech, et al.
European Urology Focus|October 6, 2020
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder CancerMarco Moschini, Luca Afferi, Giorgio Gandaglia, et al.
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
Journal of Racial and Ethnic Health Disparities|March 21, 2024
The effect of race/ethnicity on cancer-specific mortality after trimodal therapyMario de Angelis, Andrea Baudo, Carolin Siech, et al.
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
Pageof 57

Showing results (381-390 of 561) with videos related to

Sort By:
Pageof 57
BJU International|October 17, 2022
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicatorsFrancesco Del Giudice, David D'Andrea, Benjamin Pradere, et al.
Urologic Oncology|October 18, 2024
Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinomaMario de Angelis, Letizia Maria Ippolita Jannello, Carolin Siech, et al.
Journal of Racial and Ethnic Health Disparities|August 19, 2024
Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma PatientsMario de Angelis, Letizia Maria Ippolita Jannello, Carolin Siech, et al.
Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.
Prostate Cancer and Prostatic Diseases|June 21, 2022
Contemporary trends in the surgical management of urinary incontinence after radical prostatectomy in the United StatesFrancesco Del Giudice, Jianlin Huang, Shufeng Li, et al.
BJU International|March 18, 2024
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancerMario de Angelis, Andrea Baudo, Carolin Siech, et al.
European Urology Focus|October 6, 2020
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder CancerMarco Moschini, Luca Afferi, Giorgio Gandaglia, et al.
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
Journal of Racial and Ethnic Health Disparities|March 21, 2024
The effect of race/ethnicity on cancer-specific mortality after trimodal therapyMario de Angelis, Andrea Baudo, Carolin Siech, et al.
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
Pageof 57